Thursday, May 04, 2023 11:39:39 AM
The Company’s upgraded Condor Back Office (Risk Management) meets various jurisdictions’ regulatory requirements. Condor Back Office meets the directives under the Markets in Financial Instruments Directive (MiFID II/MiFIR), legislation by European Securities and Market Authority (ESMA) implemented across the European Union on January 3, 2018.
The Company is developing the Condor Investing & Trading App, a simplified trading platform for traders with varied experiences in trading stocks, ETFs, and other financial markets from their mobile phones. The Company expects to commercialize the Condor Investing & Trading App by the end of the second quarter of the fiscal year ending December 31, 2023.
The Company had developed NFT Marketplace, a decentralized NFT marketplace, a multichain platform with a lazy minting option to reduce and limit unnecessary blockchain usage fees, also known as gas fees. The Company has no plans to commercialize the NFT Marketplace in the fiscal year ending December 31, 2023, as the market for NFT has slowed considerably.
The Company and its subsidiary, ADS, intend to develop a digital wealth management company, initially including a Robo Advice Platform catering to Australia’s wealth management industry. The Company expects to commercialize the Robo Advice Platform by the fiscal year ending December 31, 2023.
Technology & Software Development Revenue & Gross Margins:
Fiscal year ended
December 31, 2022
(Audited)
Fiscal year ended
December 31, 2021
(Audited)
Revenue, $ 626,000 301,648
Cost of sales, $ 159,051 274,462
Gross Profit (loss), $ 466,949 27,186
Gross Margins, % 74.59 % 9.01 %
Recent FDCT News
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/26/2024 10:12:50 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/03/2024 10:17:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 05:27:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:35:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 02:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:58:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:10:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 05:32:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 07:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:45:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 07:00:46 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM